Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,481 | -1,310 | 4,464 | 3,340 | -26 |
| Depreciation Amortization | 8,019 | N/A | N/A | N/A | N/A |
| Other Working Capital | 533 | 1,045 | 687 | -432 | -213 |
| Other Operating Activity | 11,005 | 0 | -5,804 | -4,317 | 0 |
| Operating Cash Flow | $-4,924 | $-265 | $-653 | $-1,409 | $-239 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 284,916 | -294,688 | 0 |
| Investing Cash Flow | $N/A | $N/A | $284,916 | $-294,688 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,300 | N/A | N/A | -299 | 239 |
| Debt Repayment | -3,033 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 258 | N/A | 297,145 | N/A |
| Common Stock Repurchased | N/A | N/A | -284,916 | N/A | N/A |
| Other Financing Activity | -1,344 | 0 | 156 | -253 | 0 |
| Financing Cash Flow | $5,924 | $258 | $-284,760 | $296,594 | $239 |
| Beginning Cash Position | 4 | 11 | 497 | N/A | N/A |
| End Cash Position | 1,004 | 4 | 0 | 497 | N/A |
| Net Cash Flow | $1,000 | $-8 | $-497 | $497 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,924 | -265 | -653 | -1,409 | -239 |
| Free Cash Flow | -4,924 | -265 | -653 | -1,409 | -239 |